Research, development and strategic partnering for
the vaccine industry
"The format of the conference and the support of the conference team enhances the marketing opportunities before and during the conference."
ExpreS2ion Biotechnologies
Scientific and business development for the vaccine industry
- Delve into new technologies for vaccine development, including nanotech, synthetic biology and new-generation adjuvants
- Hear clinical phase I, II and III data from leading biotechs and big pharma
- Gain updates on the latest discovery-stage prophylactic and therapeutic vaccines
- Explore the latest methods for improving bioprocessing and manufacturing methodologies for current and future vaccines
Should you sponsor?
Why get involved?
Find out more about how you can promote your products at the vaccines sector’s premier event by downloading the sponsorship brochure today.
Why sponsor?
- Speak to a room full of vaccine experts
- Host a roundtable and meet your customers
- Let us organise 1-2-1 meetings for you
- Let us generate sales leads pre-event
- Take a private meeting room
Why exhibit?
- Show off your latest products & innovations
- Promote new services
- Educate your target market
- Generate new sales leads
- Raise brand profile
Over 50 innovative companies on display
Gold Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Showcase Sponsor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Interactive Sessions Offer High Level Networking
“The excellent program, the quality of the speakers and their relevance for the field. In terms of commercial opportunities, the former provides an opportunity to engage with the relevant leader.”
ExpreS2ion Biotechnologies
“Great networking opportunity and the level of technical talks is well targeted”
Sanofi Pasteur
“Well organised, interesting sessions, high calibre attendees supporting good networking opportunities”
MedImmune
Co-located with
Be part of the conversation
Advaxis Secures $23 Million Financing
Last week, Advaxis, Inc. (a clinical-stage biotechnology company developing cancer immunotherapies on its proprietary Lm-LLO platform technology), announced that a combined $23 million of purchase agreements ...
The post Advaxis Secures $23 Million Financing appeared first on Vaccine Nation.
Improve your Site’s chances of getting selected for future Healthy Volunteer studies
VaccineNation welcomes ClinEdge as a guest blogger. Why isn’t your research site being considered for Healthy Volunteer Vaccine Studies? Is it your site? Is it ...
The post Improve your Site’s chances of getting selected for future Healthy Volunteer studies appeared first on Vaccine Nation.
Guest blog: ViroCyt ‘Virotherapy Process Optimization’ white paper
An emerging application of viruses involves engineering them to treat diseases using a number of approaches. Broadly defined under the “Virotherapy” umbrella, these include viral ...
The post Guest blog: ViroCyt ‘Virotherapy Process Optimization’ white paper appeared first on Vaccine Nation.
